These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22826412)
1. Extrahepatic soft tissue mimicking applicator-tract implantation after percutaneous radiofrequency ablation of hepatic malignancy. Lee JK; Baek SY; Kim Y AJR Am J Roentgenol; 2012 Aug; 199(2):453-7. PubMed ID: 22826412 [TBL] [Abstract][Full Text] [Related]
2. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe]. Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Kim JE; Kim YS; Rhim H; Lim HK; Lee MW; Choi D; Shin SW; Cho SK Eur J Radiol; 2011 Aug; 79(2):e80-4. PubMed ID: 21514757 [TBL] [Abstract][Full Text] [Related]
4. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. Rhim H; Lim HK; Kim YS; Choi D AJR Am J Roentgenol; 2008 Jan; 190(1):91-8. PubMed ID: 18094298 [TBL] [Abstract][Full Text] [Related]
5. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. Chopra S; Dodd GD; Chintapalli KN; Leyendecker JR; Karahan OI; Rhim H AJR Am J Roentgenol; 2001 Aug; 177(2):381-7. PubMed ID: 11461868 [TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease. Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases. Schraml C; Clasen S; Schwenzer NF; Koenigsrainer I; Herberts T; Claussen CD; Pereira PL Abdom Imaging; 2008; 33(6):643-51. PubMed ID: 18175165 [TBL] [Abstract][Full Text] [Related]
8. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression. Park Y; Kim YS; Rhim H; Lim HK; Choi D; Lee WJ AJR Am J Roentgenol; 2009 Sep; 193(3):757-63. PubMed ID: 19696290 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940 [TBL] [Abstract][Full Text] [Related]
10. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457 [TBL] [Abstract][Full Text] [Related]
12. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740 [TBL] [Abstract][Full Text] [Related]
13. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience. Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360 [TBL] [Abstract][Full Text] [Related]
14. A radiofrequency device for tract ablation after liver biopsy: a single-institution human feasibility study. Song KD; Rhim H; Lee MW; Kang TW; Lim S Br J Radiol; 2018 May; 91(1085):20170585. PubMed ID: 29356562 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous Cholecystostomy and Hydrodissection in Radiofrequency Ablation of Liver Subcapsular Leiomyosarcoma Metastasis Adjacent to the Gallbladder: Protective Effect. Azevedo A; Falsarella P; Rocha R; Rahal A; Garcia R J Radiol Case Rep; 2016 Oct; 10(10):24-32. PubMed ID: 28580054 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous radiofrequency ablation for hepatic tumors abutting the diaphragm: clinical assessment of the heat-sink effect of artificial ascites. Nam SY; Rhim H; Kang TW; Lee MW; Kim YS; Choi D; Lee WJ; Park Y; Chang I; Lim HK AJR Am J Roentgenol; 2010 Feb; 194(2):W227-31. PubMed ID: 20093579 [TBL] [Abstract][Full Text] [Related]
18. Microwave Ablation for the Treatment of Hepatic Adenomas. Smolock AR; Cristescu MM; Potretzke TA; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Brace CL; Lee FT J Vasc Interv Radiol; 2016 Feb; 27(2):244-9. PubMed ID: 26830938 [TBL] [Abstract][Full Text] [Related]
19. [Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle]. Marone G; Francica G; D'Angelo V; Iodice G; Pastore P; Altamura G; Cusati B; Siani A Radiol Med; 1998 Jun; 95(6):624-9. PubMed ID: 9717546 [TBL] [Abstract][Full Text] [Related]
20. Percutaneous extrapulmonary radiofrequency ablation for tumors in the hepatic dome. Wang ZY; Sun WB; Li MY; Zhang XX; Ding XM Hepatogastroenterology; 2008; 55(85):1164-6. PubMed ID: 18795650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]